Search

for
Search:

GlossaryQuetiapine (Seroquel)

antipsychotic medication used to treat schizophrenia and bipolar disorder

Quetiapine, also known by the brand name Seroquel, is an antipsychotic medication used to treat mental health conditions such as schizophrenia, bipolar disorder, and major depressive disorder. It works by altering the actions of certain neurotransmitters in the brain, particularly serotonin and dopamine, to help stabilize mood and reduce symptoms like hallucinations and mood swings.

Related Terms

Sort by

Research

9 / 9 results

research Alopecia Associated with Quetiapine

19 citations, February 2007 in “International Clinical Psychopharmacology”

Quetiapine may cause hair loss, a side effect not widely recognized before.

research Trichotillomania as a Manifestation of Dementia

8 citations, January 2016 in “Case Reports in Psychiatry”

Trichotillomania in dementia may be better treated with dopamine blockers like quetiapine than with SSRIs.

research Drug-Induced Gynecomastia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

4 citations, December 2021 in “Archivio italiano di urologia andrologia”

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

research Quetiapine-Induced Hair Loss in an Adolescent Case

3 citations, February 2014 in “Anadolu psikiyatri dergisi”

A teenager's hair loss was caused by the drug quetiapine but improved after stopping the medication.

research Allopregnanolone Is Required for Prepulse Inhibition Deficits Induced by D1 Dopamine Receptor Activation

12 citations, June 2019 in “Psychoneuroendocrinology”

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

research Pediatric Bipolar Disorder: Evidence-Based Psychopharmacological Treatments

11 citations, February 2007 in “Journal of Child and Adolescent Psychiatric Nursing”

Combining mood stabilizers with antipsychotics is more effective for treating children with bipolar disorder than using mood stabilizers alone.

research Reporting on Adverse Clinical Events

March 2021 in “Clin-Alert”

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

research Reporting on Adverse Clinical Events

November 2010 in “Clin-Alert”

Monitoring for adverse effects in clinical treatments is crucial.

research Summary of Findings on Psychotropic Medications

December 2006 in “The Brown University Psychopharmacology Update”

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.